Study of CGB3002 in healthy volunteers
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 54 years old
- Be healthy overall, with no major medical conditions (like heart, lung, or liver disease)
- Have a body mass index (BMI) between 18 and 32, and weigh at least 110 lbs (50 kg) for men or 88 lbs (40 kg) for women
- Not be pregnant or planning pregnancy, and agree to use reliable birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called GSM-779690T in healthy adults. It aims to understand how the drug works in the body and check for any side effects.
This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
This trial tests a new drug called CM383 in healthy people to see how it affects the body. It may help researchers learn if CM383 is safe and how it works.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.